Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

iHSCs With the Gene Correction of HBB Intervent Subjests With β-thalassemia Mutations

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03728322
Recruitment Status : Unknown
Verified October 2018 by Allife Medical Science and Technology Co., Ltd..
Recruitment status was:  Not yet recruiting
First Posted : November 2, 2018
Last Update Posted : November 5, 2018
Sponsor:
Information provided by (Responsible Party):
Allife Medical Science and Technology Co., Ltd.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : January 2020
Estimated Study Completion Date : January 2021